IGC Pharma, Inc. (IGC) Soars in After Market After Positive Alzheimer’s Research Results
IGC Pharma, Inc. (NYSE: IGC) witnessed an unprecedented surge in its stock price following the release of encouraging phase 2 results in Alzheimer’s research. The